Announcement of Anhui Huaheng Biotechnology Co., Ltd. on the 2022 application for issuing shares to specific targets approved by the Shanghai Stock Exchange

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.